Showing results (131-140 of 660) with videos related to
Sort By:
Pageof 66
Current Oncology Reports|April 26, 2005
Second-line therapy for advanced colorectal carcinomaNaureen Starling, David CunninghamClinical Colorectal Cancer|May 6, 2005
Cetuximab in previously treated colorectal cancerNaureen Starling, David CunninghamSeminars in Oncology|January 10, 2006
The role of cetuximab in the therapy of previously treated advanced colorectal cancerGeoff Chong, David CunninghamClinical Colorectal Cancer|December 6, 2007
The role of epidermal growth factor receptor-targeted antibody therapy in previously treated colorectal cancerDavid Watkins, David CunninghamCurrent Treatment Options in Oncology|November 17, 2017
The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction CancerElizabeth Cartwright, David CunninghamEuropean Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?Alicia Okines, David CunninghamClinical Colorectal Cancer|April 12, 2008
A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patientsChristopher Jackson, David CunninghamJournal of Geriatric Oncology|February 4, 2014
Bevacizumab in elderly patients with metastatic colorectal cancerFrancesco Sclafani, David CunninghamNature Reviews. Clinical Oncology|August 12, 2015
Does surgery have a role in managing incurable gastric cancer?Sri G Thrumurthy, M Asif Chaudry, Ian Chau, et al.International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?Stanley K T Yu, Diana Tait, Ian Chau, et al.Pageof 66